Publications

Epstein-Barr virus reprograms autoreactive B cells as antigen presenting cells in SLE

Younis S et al.
Science Translational Medicine, in press.

Epstein-Barr virus reprograms autoreactive B cells as antigen presenting cells in SLE

Lanz TV et al.
Nature, 2022; 603:321-327.

Epstein-Barr virus reprograms autoreactive B cells as antigen presenting cells in SLE

Epstein–Barr virus as a potentiator of autoimmune diseases

Robinson WH and Steinman L
Science, 2022; 375(6578):264-265.

Presentation of EBV antigens on HLA class II risk alleles connects the two main risk factors of MS

Epstein–Barr virus as a potentiator of autoimmune diseases

Robinson WH et al.

Nature Reviews Rheumatology, 2024; 20(11):729-740.

Presentation of EBV antigens on HLA class II risk alleles connects the two main risk factors of MS

Sattarnezhad N et al.
Proceedings of the National Academy of Sciences (USA), 2025; 122(11):e2424986122.

Presentation of EBV antigens on HLA class II risk alleles connects the two main risk factors of MS

Lanz TV and Robinson WH
Proceedings of the National Academy of Sciences (USA), 2024; 121(49):e2420070121.

Publications

Epstein-Barr virus reprograms autoreactive B cells as antigen presenting cells in SLE

Epstein-Barr virus reprograms autoreactive B cells as antigen presenting cells in SLE

Epstein-Barr virus reprograms autoreactive B cells as antigen presenting cells in SLE

Clonally Expanded B Cells in Multiple Sclerosis Bind EBV EBNA1 and GlialCAM

Epstein-Barr virus reprograms autoreactive B cells as antigen presenting cells in SLE

Epstein-Barr virus reprograms autoreactive B cells as antigen presenting cells in SLE

Epstein-Barr virus and multiple sclerosis

Epstein-Barr virus reprograms autoreactive B cells as antigen presenting cells in SLE

Epstein–Barr virus as a potentiator of autoimmune diseases

Epstein–Barr virus as a potentiator of autoimmune diseases

Presentation of EBV antigens on HLA class II risk alleles connects the two main risk factors of MS

Epstein–Barr virus as a potentiator of autoimmune diseases

Antibody reactivity against EBNA1 and GlialCAM differentiates MS patients from healthy controls

Presentation of EBV antigens on HLA class II risk alleles connects the two main risk factors of MS

Presentation of EBV antigens on HLA class II risk alleles connects the two main risk factors of MS

Presentation of EBV antigens on HLA class II risk alleles connects the two main risk factors of MS

Presentation of EBV antigens on HLA class II risk alleles connects the two main risk factors of MS

Presentation of EBV antigens on HLA class II risk alleles connects the two main risk factors of MS

Publications

Epstein-Barr virus reprograms autoreactive B cells as antigen presenting cells in SLE

Epstein-Barr virus reprograms autoreactive B cells as antigen presenting cells in SLE

Epstein-Barr virus reprograms autoreactive B cells as antigen presenting cells in SLE

Clonally Expanded B Cells in Multiple Sclerosis Bind EBV EBNA1 and GlialCAM

Epstein-Barr virus reprograms autoreactive B cells as antigen presenting cells in SLE

Epstein-Barr virus reprograms autoreactive B cells as antigen presenting cells in SLE

Epstein-Barr virus and multiple sclerosis

Epstein-Barr virus reprograms autoreactive B cells as antigen presenting cells in SLE

Epstein–Barr virus as a potentiator of autoimmune diseases

Epstein–Barr virus as a potentiator of autoimmune diseases

Presentation of EBV antigens on HLA class II risk alleles connects the two main risk factors of MS

Epstein–Barr virus as a potentiator of autoimmune diseases

Antibody reactivity against EBNA1 and GlialCAM differentiates MS patients from healthy controls

Presentation of EBV antigens on HLA class II risk alleles connects the two main risk factors of MS

Presentation of EBV antigens on HLA class II risk alleles connects the two main risk factors of MS

Presentation of EBV antigens on HLA class II risk alleles connects the two main risk factors of MS

Presentation of EBV antigens on HLA class II risk alleles connects the two main risk factors of MS

Presentation of EBV antigens on HLA class II risk alleles connects the two main risk factors of MS

This website uses cookies.